Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study-Reference-Cited by-同舟云学术

Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study

Published:2014-03-03 Issue:9 Volume:15 Page:513-524
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Tudor-Williams G¹,Cahn P²,Chokephaibulkit K³,Fourie J⁴,Karatzios C⁵,Dincq S⁶,Opsomer M⁶,Kakuda TN⁷^ORCID,Nijs S⁶,Tambuyzer L⁶,Tomaka FL⁷,

Affiliation:

1. Imperial College; London UK

2. Fundación Huésped; Buenos Aires Argentina

3. Mahidol University; Bangkok Thailand

4. Dr Jan Fourie Medical Practice; Dundee KwaZulu-Natal South Africa

5. McGill University Health Centre; Montréal Canada

6. Janssen Infectious Diseases BVBA; Beerse Belgium

7. Janssen Research & Development LLC; Titusville NJ USA

Funder

Janssen Research and Development

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference43 articles.

1. Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges;Phelps;Paediatr Drugs,2011

2. Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study;Menson;BMJ,2006

3. PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection;Welch;HIV Med,2009

4. Department of Health and Human Services Guidelines for the use of antiretroviral agents in pediatric HIV infection 2014 http://aidsinfo.nih.gov/guidelines/html/2/pediatric-arv-guidelines/0/

5. Effect of first line therapy including efavirenz and two nucleoside reverse transcriptase inhibitors in HIV-infected children;Funk;Eur J Med Res,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring of antiretroviral drugs for the management of human immunodeficiency infection;Therapeutic Drug Monitoring;2024

2. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand;Antiviral Therapy;2022-06

3. Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age;AIDS;2021-04-14

4. Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV;Pharmaceuticals;2020-06-11

5. Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review;Clinical Pharmacokinetics;2019-11-02